Premium
Enalapril‐induced toxic pustuloderma
Author(s) -
FERGUSON J.E.,
CHALMERS R.J.G.
Publication year - 1996
Publication title -
clinical and experimental dermatology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.587
H-Index - 78
eISSN - 1365-2230
pISSN - 0307-6938
DOI - 10.1111/j.1365-2230.1996.tb00014.x
Subject(s) - enalapril , discontinuation , medicine , heart failure , rash , cardiology , pharmacology , angiotensin converting enzyme , blood pressure
Summary Enalapril is widely prescribed for hypertension and cardiac failure. Rashes arc an uncommon side‐effect, occurring in approximately 1.4% of patients, and in approximately 0.4% of patients the rash is sufficient to require discontinuation of enalapril. (Merck Sharp and Dohme, pers. comm.) We report a case of toxic pustuloderma related to enalapril therapy for congestive cardiac failure. To our knowledge enalapril‐induced toxic pustuloderma has not been previously reported.